DNA damage-induced translocation of S100A11 into the nucleus regulates cell proliferation by Gorsler, Theresa et al.
RESEARCH ARTICLE Open Access
DNA damage-induced translocation of S100A11
into the nucleus regulates cell proliferation
Theresa Gorsler
1,3, Ulrike Murzik
1,4, Tobias Ulbricht
2, Julia Hentschel
1, Peter Hemmerich
2, Christian Melle
1,5*
Abstract
Background: Proteins are able to react in response to distinct stress stimuli by alteration of their subcellular
distribution. The stress-responsive protein S100A11 belongs to the family of multifunctional S100 proteins which
have been implicated in several key biological processes. Previously, we have shown that S100A11 is directly
involved in DNA repair processes at damaged chromatin in the nucleus. To gain further insight into the underlying
mechanism subcellular trafficking of S100A11 in response to DNA damage was analyzed.
Results: We show that DNA damage induces a nucleolin-mediated translocation of S100A11 from the cytoplasm
into the nucleus. This translocation is impeded by inhibition of the phosphorylation activity of PKCa. Translocation
of S100A11 into the nucleus correlates with an increased cellular p21 protein level. Depletion of nucleolin by siRNA
severely impairs translocation of S100A11 into the nucleus resulting in a decreased p21 protein level. Additionally,
cells lacking nucleolin showed a reduced colony forming capacity.
Conclusions: These observations suggest that regulation of the subcellular distribution of S100A11 plays an
important role in the DNA damage response and p21-mediated cell cycle control.
Background
Cells are exposed to changing environmental conditions
that can cause cellular stress. Stress-inducing situations
include severe variations of the cellular energy budget,
altered concentration of specific ions and also condi-
tions that induce DNA damage. In case of DNA
damage, cell cycle arrest or illegitimate DNA rearrange-
ments, cell death or carcinogenesis can occur if cellular
systems fail to repair the DNA properly [1]. As a conse-
quence, the integrity of the genome is threatened.
Response mechanisms of cells to genotoxic stress
include directed intracellular trafficking of specific pro-
teins mediated commonly by posttranslational modifica-
t i o n sa sw e l la sf o r m a t i o no fs p e c i f i cp r o t e i n - p r o t e i n
interactions [2-4]. In a recent study, we showed a func-
tional cooperation of S100A11 with the repair machin-
ery at sites of DNA double-strand breaks (DSBs) [5].
S100A11 belongs to the family of S100 proteins which
are considered as multitasking proteins involved in sev-
eral biological processes such as the Ca
2+ signalling
network, cell growth and motility, cell cycle progression,
transcription and cell differentiation [6-8]. It has been
proposed that the S100 proteins are involved in the dif-
ferentiation of specific tissues and that some members
of this family are differentially expressed in normal
human skin and melanocytic lesions [9]. S100 proteins
are expressed in a cell and tissue specific manner [10].
In several studies, S100A11 was shown to be up- or
down-regulated in different tumor entities [11,12].
S100A11 plays a dual role in growth regulation of
human keratinocytes as it is able to mediate a Ca
2+-
induced growth inhibition as well as growth stimulation
by enhancement of the level of EGF protein family
members [13,14]. Interestingly, the stimulation of the
activity of the cell cycle regulator p21
WAF1/CIP1 by
potential cellular stress stimuli such as increase of extra-
cellular Ca
2+ concentration as well as induction of DNA
damage can be mediated by S100A11 through a p53
independent mechanism [5,13].
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Cell culture
The human keratinocyte cell line HaCaT [15] and
human U-2 OS osteosarcoma cells were cultured in
DMEM supplemented with 10% fetal bovine serum.
Cells were grown to 80% confluence and passaged at a
split ratio of 1:4. For western blot experiments, cells
were harvested at 70-90% confluency and lysed in a buf-
fer containing 100 mM sodium phosphate pH 7.5, 5
mM EDTA, 2 mM MgCl2,0 . 1 %C H A P S ,5 0 0μMl e u -
peptin, and 0.1 mM PMSF. After centrifugation (15 min;
15000 rpm) the supernatant was immediately applied to
SDS-PAGE. Preparations of cytoplasmic and nuclear cell
fractions were performed using the ProtoJET cytoplas-
mic and nuclear protein extraction kit (Fermentas)
according to the manufactor’s instructions.
Construction of the GFP-S100A11 plasmid
An S100A11 construct from a pGEX-2T-S100A11 vec-
tor (kindly provided by Dr. N.H. Huh, Okayama Univer-
sity) was PCR amplified using following primers:
5’-gcttcgaattctatggcaaaaatctccagccc-3’ (sense) and
5’-ggtggatccggtccgcttctgggaaggga-3’ (antisense). The PCR
fragment was cloned between the EcoR1 and BamH1
restriction site of pEGFP-C1 (Clontech). Correct inser-
tion of S100A11 was confirmed by sequencing.
siRNA mediated knockdown of nucleolin
Small interfering RNA (siRNA) duplex oligonucleotides
used in this study are based on the human cDNAs encod-
ing nucleolin. Nucleolin siRNA as well as a non-silencing
control siRNA were obtained from QIAGEN GmbH
(Hilden, Germany). The siRNA sequence applied to target
nucleolin was 5’-AAG AAC GTG GCT GAG GAT GAA-
3’. The siRNA sequences employed as negative controls
were 5’-UUC UCC GAA CGU GUC ACG UdTdT-3’
(sense) and 5’-ACG UGA CAC GUU CGG AGA AdTdT-
3’ (antisense). HaCaT cells (2 × 10
5)w e r ep l a t e do n6 - w e l l
plates 18 hours prior to transfection and were 50% conflu-
ent when siRNA was added. The amount of siRNA
duplexes applied was 1.5 μg/well for nucleolin. Transfec-
tion was performed using the amphiphilic delivery system
SAINT-RED (Synvolux Therapeutics B.V., Groningen, The
Netherlands) as described [5]. Briefly, siRNA was com-
plexed with 15 nmol of transfection reagent and added to
the cells for 4 hours. Subsequently, 2 ml of culture med-
ium was added and incubation proceeded for 72 hours.
Antibodies for immunofluorescence-based microscopy
Anti-S100A11 chicken polyclonal antibody (ab15612;
Abcam), anti-nucleolin mouse monoclonal antibody
(4E2; MBL) and anti-gH2AX rabbit polyclonal antibody
raised in rabbits against a phosphorylated peptide
corresponding to the C-terminus of human gH2AX
were used in two- or three-color immunofluorescence
staining as primary antibodies which were detected with
species-specific secondary antibodies linked to fluores-
cein, Cy3 or Cy5 (Dianova).
Immunocytochemistry and confocal microscopy
Cells grown on coverslips were fixed by treatment with
methanol at -20°C for 5 min followed by acetone (pre-
chilled to -20°C) for 3 min, or by incubation in 4% par-
aformaldehyde for 10 min at room temperature followed
by 25% Triton-X 100 for 3 min. Immunofluorescence
was performed as previously described [5]. Samples
were scanned with a Zeiss LSM 510 laser scanning con-
focal device attached to an Axioplan 2 microscope using
a 63× Plan-Apochromat oil objective (Carl Zeiss, Jena,
Germany). Fluorescein, Cy3 or Cy5 dyes were excited by
laser light at a 488-, 552-, or 633-nm wavelength,
respectively. To avoid bleed-through effects in double or
triple staining experiments, each dye was scanned inde-
pendently using the multitracking function of the LSM
510 unit. Single optical sections were selected either by
eye-scanning the sample in z axis for optimal fluores-
cence signals, or selected from z-stacks. Images were
electronically merged using the LSM 510 (Carl Zeiss,
Jena, Germany) software and stored as TIFF files. Fig-
ures were assembled from the TIFF files using Adobe
Photoshop software.
Induction of DNA damages by bleomycin (BLM)
Cells were seeded in 6-well plates on cover slips for
16 hours. DMEM supplemented with 10% FCS was
exchanged to fresh DMEM supplemented with 10% FCS
and cells were treated with 12.5 IU/ml BLM. Medium
was exchanged after 30 minutes and cells were analyzed
after different time points. DNA double-strand breaks
(DSBs) were visualized by immunofluorescence using a
specific antibody against gH2AX. H2AX becomes phos-
phorylated as one of the first cellular responses after
DNA damage and forms foci at sites of DSBs [16].
Quantification of S100A11 translocation
The GFP-S100A11 fluorescence signal was quantified
from maximum intensity projections of 3-D image
stacks of U-2 OS cells treated with BLM for 30 min or
in untreated control cells, Quantification was done with
MetaMorph analysis software (MDS Analytical Technol-
ogies). Fluorescence intensity of GFP-S100A11 in five
cytoplasmic areas (2 μm diameter each) localized along
a straight line from the nuclear membrane to the cellu-
lar periphery in four different directions based on the
nuclear membrane as well as of three areas randomly
selected in the nucleus was measured.
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Proteins of interest in crude extracts of U-2 OS and
HaCaT cells treated with specific nucleolin siRNA or
unspecific control siRNA were verified using specific
antibodies against nucleolin (mouse monoclonal, 4E2;
MBL), actin (rabbit polyclona l ,A 2 6 6 ;S i g m a ) ,S 1 0 0 A 1 1
(rabbit polyclonal,10237-1-AP; Protein Tech Group),
Ku70 (mouse monoclonal, AB-4/N3H10; Labvision),
tubulin (rabbit polyclonal, ab18251; Abcam), and p21
(rabbit polyclonal, sc-469; Santa Cruz) by Western blot
assays as described.
qRT-PCR
HaCaT cells transfected with specific nucleolin or con-
trol siRNA were treated with BLM (12.5 IU/μl) for 1 h.
Total RNA was extracted using an RNA Isolation Kit
(Qiagen, Germany) and first strand synthesis was
synthesized using a Kit system (Fermentas, Germany)
according to the manufacturer’s instructions. The
mRNA level of the p21 gene was estimated by quantita-
tive real-time PCR using specific primers: p21 fwd
5’ CTG TCA CTG TCT TGT ACC CTT GT 3’; p21 rev
5’ CTT CCT GTG GGC GGA TTA G 3’. The CT value
of the p21 gene was normalized to actin.
Colony forming assay
To assess the survival rate of cells after bleomycin treat-
ment, 10
4 HaCaT cells were seeded into 6-well dishes.
After 24 hours, the cells were treated with different con-
centrations of the drug and cultured for another ten
days. In control treatments, single cells had formed
colonies of about 30 cells after that time. Colonies were
than washed once with PBS, fixed with methanol for
15 min, stained with Giemsa dye, and finally air-dried.
The number of colonies formed was then determined.
Results
Nuclear translocation of S100A11 is induced by stress
stimuli
It was shown recently that S100A11 is involved in the
detection of DNA double-strand breaks (DSBs) by the
DNA repair machinery [5]. When human HaCaT kerati-
nocytes were treated with bleomycin (BLM), a DNA
double-strand break (DSB)-inducing agent, an increased
accumulation of S100A11 at discrete foci in the nucleus,
accompanied by a decreased staining in the cytoplasm
was detectable compared to untreated control cells (Fig-
ure 1A). Consistent with previous observations [5], we
detected a distribution of endogenous S100A11 in a
dot-like pattern in the nucleus of DNA damaged cells.
This behaviour of S100A11 is reminiscent of its nuclear
translocation induced by high Ca
2+ as reported pre-
viously [13]. Quantification of the S100A11 cellular
redistribution was not possible in HaCaT cells due to
the small cytoplasmic volume. We therefore used
human osteosarcoma (U-2 OS) cells which, in contrast
to HaCaT cells, have a large cytoplasmic volume.
Because U-2 OS cells express only very little endogen-
ous S100A11 [Additional file 1: Supplemental Figure
S1], we quantified the translocation event in cells
expressing GFP-tagged S100A11. To simultaneously
investigate whether other cellular stress stimuli are also
able to induce a directed translocation of the GFP-
S100A11 into the nucleus we treated the cells with
extracellular Ca
2+ or bleomycin (BLM). Similar to endo-
genous S100A11 in HaCaT cells, the GFP-S100A11 con-
struct was translocated into the nucleus of U-2 OS cells
by Ca
2+ as well as BLM treatment (Figure 1B). Interest-
ingly, introduction of DSBs by BLM was more effective
than Ca
2+ in induction of S100A11 nuclear translocation
as assessed in a kinetic approach. An almost complete
translocation of GFP-S100A11 into the nucleus of U-2
OS cells was induced 30 minutes after BLM treatment
compared to addition of Ca
2+ which triggered only a
partial translocation to the perinuclear region at this
time point. A significant translocation of S100A11
occurred only after 6 hours after Ca
2+ treatment. This
observation suggests that the dynamics of cellular
S100A11 redistribution is stress type dependent. The
translocation of GFP-S100A11 was specific as cells
transfected with GFP alone showed a random cellular
distribution pattern of the GFP signal after induction of
DNA damage by BLM [Additional file 2: Supplemental
Figure S2].
To quantify the directed translocation of S100A11
from the cytoplasm into the nucleus we defined five
circled areas (each 2 μm in diameter) localized along a
line from the nuclear membrane to the cellular periph-
ery as well as areas (5 μm diameter) randomly selected
in the nucleus (Figure 2A). Altogether, a cytosolic area
of at least 10 μm in distance to the nuclear membrane
was analyzed by this approach. The average fluorescence
intensity of the GFP-S100A11 signal of the five specific
cytosolic areas was determined radially in four different
cytosolic directions based on the nuclear membrane and
in the nuclear areas using MetaMorph software 30 min-
utes after treatment with BLM (Figure 2B). With this
approach we detected an increase of GFP-S100A11
signal in the nucleus of DNA damaged U-2 OS cells
compared to control cells. Simultaneously, the GFP-
S100A11 signal decreased in the cytoplasm of BLM-
treated cells. The effect was observed in the peripheral
cytosolic area. Thus, induction of DNA damage by BLM
triggers a directed translocation of S100A11 from the
cytoplasm into the nucleus. In contrast, the distribution
of GFP-S100A11 was almost similar in various locations
throughout the cytoplasm of untreated control cells
(Figure 2B). Furthermore, a similar nuclear translocation
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able in another cell line [Additional file 3: Supplemental
Figure S3]. These data demonstrate that DNA damage is
a powerful stress stimulus to activate a directed translo-
cation of S100A11 into the nucleus of human cells.
Nuclear translocation of S100A11 is mediated by
nucleolin
Nucleolin has been previously implicated in the cellular
translocation of S100A11 after treatment with extracel-
lular Ca
2+ [13]. We therefore analyzed the role of
nucleolin in DNA damage-induced S100A11 nuclear
accumulation. A prerequisite of the nuclear transport of
S100A11 is a specific phosphorylation of S100A11 by
PKCa which is activated by high Ca
2+ [17]. Phoshoryla-
tion of S100A11 triggers its binding to nucleolin.
Nucleolin is involved in several cellular processes such
as ribosomal assembly and maturation, signal transfor-
mation as well as shuttling activities [18-20]. Therefore,
we assessed if nucleolin is also involved in a directed
translocation of S100A11 induced by DNA damage. The
induction of DSBs by BLM caused in GFP-S100A11
transfected U-2 OS cells a redistribution of a fraction of
cellular nucleolin to the perinuclear region (Figure 3A).
Redistribution was absent in control cells containing
GFP-S100A11 without BLM treatment. A higher degree
of colocalization was detected between GFP-S100A11
and nucleolin in the perinuclear region of BLM treated
cells which was not detectable in controls (Figure 3A,
insets). Again, an increased distribution of GFP-
S100A11 in perinuclear regions and nucleus appeared
after induction of DNA damage. To confirm that
nucleolin is able to specifically transfer the poshosphory-
lated form of S100A11 into the nucleus, PKCa was
inhibited using a myristoylated PKC inhibitor [21]. The
cellular distribution of GFP-S100A11 and nucleolin was
then examined by immunofluorescence staining fol-
lowed by confocal laser scanning microscopy. Because
specific phosphorylation of S100A11 is a prerequisite for
nuclear transfer triggered by a high Ca
2+ stimulus, we
expected that the phosphorylation event may be also
necessary for S100A11 translocation into the nucleus
induced by DNA damages. In U-2 OS cells containing
damaged DNA, GFP-S100A11 was translocated directly
Figure 1 Translocation of S100A11 into the nucleus of human U-2 OS cells after stress stimulation. (A) Fixed human HaCaT keratinocytes
treated with bleomycin (BLM) for 30 min were immunostained with anti-S100A11 antibody. In BLM treated cells decreased staining in the
cytoplasm as well as increased staining in the nucelus can be observed. (B) U-2 OS cells transfected with GFP-S100A11 were treated with CaCl2
(10 mM) or BLM (12.5 IU/ml), and analyzed by immunostaining followed by laser scanning microscopy for GFP-S100A11 and for gH2AX at
different time points at indicated.
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cells incubated with the PKC inhibitor only very little
GFP-S100A11 was detectable in the nucleus. GFP fluor-
escence intensity in these cells was similar to control
cells (Figure 3B). The altered cellular distribution of
GFP-S100A11 after treatment with BLM and/or the
myristoylated PKC inhibitor is also reflected by the dis-
tinct GFP-S100A11 pattern in cytoplasmic as well as
nuclear cell fractions (Figure 3D). To evaluate the influ-
ence of nucleolin on the nuclear translocation of endo-
genous S100A11 more specifically, nucleolin was
depleted in HaCaT cells using siRNA (Figure 4). The
amount of nuclear S100A11 was quantified in HaCaT
keratinocytes under several conditions. A significant
increase of nuclear S100A11 was detectable in cells with
damaged DNA compared to untreated control cells. The
increase of endogenous S100A11 in the nucleus is
comparable to the amount of translocated GFP-
S100A11 into nuclei of U-2 OS cells triggered by DNA
damage. Additionally, we found similar intensities of
nuclear S100A11 in nucleolin-depleted cells and in con-
trol cells. Induction of DNA DSBs by BLM in cells lack-
ing nucleolin did result in an only slightly intensified
translocation of endogenous S100A11 into the nucleus
compared to untreated cells lacking nucleolin (Figure 4).
Impeded nuclear translocation of S100A11 inhibits
cell proliferation
Recently, we showed that the depletion of S100A11
leads to an inhibition of DNA damage-induced up-
regulation of the cell cycle regulator p21 [5]. Therefore,
we were interested whether inhibition of S100A11 trans-
location into nuclei after depletion of nucleolin also
induces a decrease of p21. HaCaT cells transfected with
Figure 2 Quantification of S100A11 translocation in stress stimulated cells. The translocation of GFP-S100A11 in U-2 OS cells which were
treated with BLM for 30 min to induce DNA double strand breaks (DSB) or in control cells was quantified by measurement of the average GFP-
S100A11 fluorescence intensity in different areas within the cytoplasm as well as in the nucleus using MetaMorph analysis software as described
in Materials and Methods. (A) The fluorescence intensity of GFP-S100A11 in five cytoplasmic areas (2 μm diameter each; stained in red, light
green, violet, green and pink, respectively) localized at the nuclear membrane to cellular periphery in four different directions based on the
nuclear membrane as well as of three areas (5 μm diameter each; stained in blue) randomly selected in the nucleus was measured radially. (B)
Quantification of the GFP-S100A11 fluorescence signal in the cytoplasmatic areas and in nuclear areas of BLM-treated U-2 OS cells (n = 20) (grey
column) or in control cells (n = 20) (white column). Data are displayed as mean values (±SD). Translocation of GFP-S100A11 in DNA damaged
cells was significant between all examined areas.
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induce DNA DSBs for 30 min or left untreated. This
analysis revealed a significant reduction of p21 protein
levels in nucleolin-depleted cells (Figure 5A). The reduc-
tion of p21 was independent of BLM treatment in
HaCaT cells. These observations demonstrate that
nucleolin-directed translocation of S100A11 into the
nucleus is required for the induction of p21 and confirm
our previous results [5]. Consistent with these data, the
transcriptional activation of p21 gene expression was
also decreased in HaCaT cells lacking nucleolin (Figure
5B). Additionally, the p21 protein level was decreased
when S100A11 phosphorylation was inhibited in cells
treated with BLM (Figure 5C). Finally, we determined
the proliferation capacity of nucleolin depleted HaCaT
cells in colony-forming assays (Figure 5D). A significant
decrease of the colony forming capacity of cells lacking
nucleolin was observed (Figure 5D). Nucleolin depletion
also induced an increase of the subG1/apoptotic fraction
by a factor of three in FACS analyses (data not shown).
Similar results were previously obtained after S100A11
knock-down [5], supporting our conclusion that nucleo-
lin and S100A11 function in concert during DNA
damage response pathways.
Discussion
S100 proteins are involved in Ca
2+-modulated signal
transduction pathways [22,23]. A translocation of
S100A11 induced by Ca
2+ as a cellular stress stimulus
might be a key mechanism to regulate the formation of
specific signalling complexes in a spatially and tempo-
rally regulated manner [13,24]. The data reported in the
present study indicate a direct translocation of S100A11
into the nucleus induced by DNA damage. Recently, we
showed that S100A11 seems to be involved in DNA
repair processes because it functionally interacts with
Rad54B which is involved in homologous recombination
[5]. This interaction targets Rad54B to sites of DNA
double-strand break (DSB) repair. Several members of
the S100 protein family are transcriptionally regulated
Figure 3 Nucleolin distribution during nuclear translocation of S100A11 in DNA damaged cells. (A) U-2 OS cells which expressed GFP-
S100A11 were treated with BLM to induce DSB for 1 h followed by immuno-staining against GFP-S100A11 (green), nucleolin (red) and gH2AX
(blue). The overlay image (merge) shows that GFP-S100A11 and nucleolin partially colocalize in the perinuclear region (labeled by arrows) in cells
containing damaged DNA compared to control cells. Areas marked by a rectangle are shown enlarged in each image as insets. (B) Inhibition of
phosphorylation of S100A11 by a myristolated PKC inhibitor interferes with S100A11 translocation. U-2 OS cells were transfected with a GFP-
S100A11 construct and treated with BLM for 30 min or pre-treated with a PKC inhibitor for 17 hrs and subsequently with BLM. Cells were
analyzed by two-color immunostaining followed by laser scanning microscopy for GFP-S100A11 (green) and gH2AX (red). (C) Quantification of
the GFP-S100A11 relative fluorescence intensity (RFI) in nuclei of cells treated with BLM or BLM and a PKC inhibitor and in control cells by
assessment of the GFP-S100A11 fluorescence intensity in several nuclear areas (2 μm diameter) in percent. At least 14 cells for each condition
were analyzed for quantification. Data are displayed as mean values (±SD). The average of the GFP-S100A11 fluorescence intensity measured in
the control approach was set as 100%. (D) U-2 OS cells which expressed GFP-S100A11 were treated with BLM or with both BLM and the
myristoylated PKC inhibitor. Afterwards, cytoplasmic as well as nuclear cell extract of treated cells and, as control, untreated cells were prepared
and subjected to immunoblotting using a specific antibody against S100A11. As control for equal protein loading immunoblotting against
nuclear protein Ku70 or cytosolic actin using specific antibodies were carried out.
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cycle control [25-27]. Additionally, it was also shown
that the expression of S100A8, a further S100 family
protein, was stimulated by UV-A radiation in a mouse
model [28]. Directed translocation of proteins seems to
be a general response to different cellular stress stimuli,
including S100 family members [13,29-32]. Such nucleo/
cytoplasmic translocations occur in both directions. We
have shown here that nuclear translocation of S100A11
was triggered not only by Ca
2+ as previously described,
but also by DNA damage. The accumulation of S100A11
in nuclei was more effective after DNA damage com-
pared to the Ca
2+ stimulus. This may be related to very
strong stress signals usually associated with DNA breaks.
The S100A11 translocation triggered by DNA damage is,
at least partly, mediated by nucleolin (Figure 4). Nucleo-
lin was described as a shuttling protein which is involved
in directed translocation into the nucleus of several pro-
teins [33-35]. Interestingly, a redistribution of nucleolin
from nucleoli to perinuclear regions as well as a colocali-
zation between S100A11 and nucleolin in these regions
after treatment with the DNA damaging agent BLM
Figure 4 Down-regulation of nucleolin interferes with translocation of endogenous S100A11. (A) HaCaT cells treated with BLM for 30 min
or control cells were transfected with specific siRNA for depletion of nucleolin (nucleolin siRNA) or, as a control, unspecific nonsilencing siRNA
(control siRNA), respectively. Cells were analyzed by laser scanning confocal microscopy using specific antibodies against S100A11 and nucleolin.
(B) Quantification of the nuclear localization of endogenous S100A11 in human HaCaT keratinocytes transfected with a specific nucleolin siRNA
or, as control, an unspecific control siRNA. Transfected cells were treated with BLM for 30 min and the relative fluorescence intensity (RFI) of the
S100A11 signal in selected areas (2 μm diameter) was assessed in several nuclear areas by a specific anti-S100A11 antibody as well as in
untreated cells. At least 25 cells were analyzed for each condition. Data are displayed as mean values (±SD). The average of the S100A11
fluorescence intensities measured in untreated control cells transfected with control siRNA was set as 100%.
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nucleolin by RNA interference as well as inhibition of
S100A11 phosphorylation by a myristoylated PKC inhibi-
tor inhibited the directed translocation of S100A11 into
the nucleus in DNA damaged cells. Nevertheless, as
minor S100A11 signal intensities still appeared in cells
lacking nucleolin or cells incubated with the PKC inhibi-
tor, it is tempting to speculate about the existence of
further nuclear transfer mechanisms for S100A11. Addi-
tionally, it is conceivable that endogenous S100A11 as
well as the S100A11-GFP fusion is able to diffuse pas-
sively into the nucleus due to its small molecular size.
After induction of the nuclear translocation of
S100A11 by DNA damage in HaCaT keratinocytes the
protein level of the cell cycle regulator p21 increased
significantly. These data are consistent with recently
published results showing an increased p21 protein level
in DNA damaged cells [5]. The activation of p21 must
be p53 independent as HaCaT cells possess only an
inactive form of p53 that is not able to induce p21 [36].
Figure 5 Depletion of nucleolin induced downregulation of p21 and impeded cell proliferation. (A) Protein extract of human HaCaT cells
transfected with specific nucleolin siRNA (lanes 1-2) or unspecific control siRNA (lanes 3-4) which were treated with BLM for 30 min (lanes 2 and
4) or untreated cells (lanes 1 and 3) were subjected to immunoblotting against nucleolin and p21 using specific antibodies. As a control for
equal protein loading corresponding actin levels are shown by immunoblot. (B) HaCaT keratinocytes transfected with specific nucleolin siRNA or
unspecific control siRNA were cultured for 72 h and treated for 1hour with BLM (12.5 μg/ml). Then total RNA was extracted from the cells and
p21 gene expression analysis was performed. The CT values of p21 were normalized to actin. Two independent experiments were performed
and data are displayed as mean values (±SD). (C) HaCaT cells treated with BLM, the myristoylated PKC inhibitor, or both BLM and PKC inhibitor,
and, as a control, untreated cells were lysed and protein extracts were subjected to immunoblotting using a specific antibody against p21. As a
control for equal protein loading corresponding actin levels are shown by immunoblot. (D) Decreased proliferation capacity of nucleolin-
depleted HaCaT cells. For assessment of the proliferation capacity of HaCaT keratinocytes, colony formation assays were carried out. HaCaT cells
were transfected with a specific nucleolin siRNA or, as a control, with unspecific control siRNA, treated with BLM 72 h after transfection and
grown for further 7 d (+BLM). As a control, transfected cells grown without BLM treatment (-BLM). For quantification, the colonies in 3
representative areas (1.0 cm diameter) of 6-well dishes with transfected HaCaT cells with (+BLM) or without (-BLM) BLM treatment were counted.
Data are displayed as mean values (±SD).
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for the regulation of the p21 level in HaCaT cells. The
regulation of p21 in a p53 independent manner seems
to correlate with depletion of S100A11 as shown else-
where [5] or inhibition of the S100A11 translocation
into the nucleus as shown here. Our studies also
revealed that depletion of nucleolin inhibits transcrip-
tional activation of the p21 gene. This was not expected
because data of Sakaguchi et al. suggested that a tran-
scriptional activator of p21, Sp1, can be liberated from
nucleolin by the binding of nuclear S100A11 to nucleo-
lin [13]. We suggest that p21 may be controlled under
these circumstances by an as yet unknown mechanism
that involves S100A11. Finally, we have shown that
reduced S100A11 levels in the nucleus diminished the
proliferation capacity of HaCaT keratinocytes. Since p21
can act as an inhibitor of apoptosis [37] it is not surpris-
ing that the decrease of nuclear S100A11 followed by
reduction of p21 induced an increased apoptotic cell
fraction.
Conclusions
On the basis of these data it seems that S100A11 is able
to mediate a cellular stress stimulus induced by DNA
damage by nucleolin-mediated translocation into the
nucleus and regulation of p21 activity.
Additional material
Additional file 1: Expression analysis of S100A11 protein in
different human cell lines by immunoblotting. Protein extracts of U-2
OS osteosacroma cells (lane 1) and HaCaT keratinocytes (lane 2) were
subjected to immunoblotting against endogenous S100A11 using a
specific antibody. As a control for equal protein loading corresponding
actin levels were shown by immunoblot.
Additional file 2: Distribution of GFP in DNA damaged U-2 OS cells.
U-2 OS cells were transfected with a GFP construct, treated with
bleomycin (BLM; 12.5 IU/ml) for 30 min and analyzed by two-color
immunostaining followed by laser scanning microscopy for GFP (green)
and for gH2AX (red) 30 min after BLM treatment.
Additional file 3: Translocation of S100A11 into the nucleus of
human A431 cells after stress stimulation. Fixed cells treated with
bleomycin (BLM) for 30 min were immunostained with anti-S100A11
antibody and anti-gH2AX antibody. In BLM treated cells increased
staining of S100A11 in the nucleus can be observed.
Acknowledgements
The pGEX-2T-S100A11 vector used in this study was kindly provided by Dr.
N.H. Huh (Okayama University). This study was supported by a grant of the
Wilhelm Sander-Stiftung to C.M. C.M. thanks F. von Eggeling for continuous
support.
Author details
1Core Unit Chip Application (CUCA), Institute of Human Genetics and
Anthropology, University Hospital Jena, 07740 Jena, Germany.
2Department
of Molecular Biology, Fritz Lipmann Institut (FLI) - Leibniz Institute for Age
Research, 07743 Jena, Germany.
3Current Address: Abt. Molekulare
Onkologie, Universitätsmedizin Göttingen, Georg-August-Universität, 37077
Göttingen, Germany.
4Current Address: Membrane Trafficking Group; Fritz
Lipmann Institut (FLI) - Leibniz Institute for Age Research, 07743 Jena,
Germany.
5Current Address: Biomolecular Photonics Group, University
Hospital Jena, 07740 Jena, Germany.
Authors’ contributions
TG carried the immunofluorescence-based and Western blot experiments
out, generated the EGFP-S100A11 construct and was involved in analyzing
the data. UM was involved in immunofluorescence analyses. TU was
involved in the quantification of translocation experiments. JH carried out
the qRT-PCR. PH was involved in analyzing the immunofluorescence data
and helped to draft the manuscript. CM conceived the study, was involved
in analyzing the data, and drafted the manuscript. All authors have read and
approved the final manuscript.
Received: 11 June 2010 Accepted: 17 December 2010
Published: 17 December 2010
References
1. Hoeijmakers JH: Genome maintenance mechanisms for preventing
cancer. Nature 2001, 411:366-374.
2. Agarwal R, Cohen-Fix O: Phosphorylation of the mitotic regulator Pds1/
securin by CdC28 is required for efficient nuclear localization of Esp1/
separase. Genes Dev 2002, 16:1371-1382.
3. Lo KW, Kan HM, Chan LN, Xu WG, Wang KP, Wu Z, Sheng M, Zhang M: The
8-kDa dynein light chain binds to p53-binding protein 1 and mediates
DNA damage-induced p53 nuclear accumulation. J Biol Chem 2005,
280:8172-8179.
4. Kubota Y, Takanami T, Higashitani A, Horiuchi S: Localization of X-ray cross
complementing gene 1 protein in the nuclear matrix is controlled by
casein kinase II-dependent phosphorylation in response to oxidative
damage. DNA Repair 2009, 8:953-960.
5. Murzik U, Hemmerich P, Weidtkamp-Peters S, Ulbricht T, Bussen W,
Hentschel J, von Eggeling F, Melle C: Rad54B targeting to DNA double-
strand break repair sites requires complex formation with S100A11. Mol
Biol Cell 2008, 19:2926-2935.
6. Donato R: S100, a multigenic family of calcium-modulated proteins of
the EF-hand type with intracellular and extracellular functional roles. Int
J Biochem Cell Biol 2001, 33:637-668.
7. Eckert RL, Broome AM, Ruse M, Robinson N, Ryan D, Lee K: S100 proteins
in the epidermis. J Invest Dermatol 2004, 123:23-33.
8. Leclerc E, Fritz G, Vetter SW, Heizmann CW: Binding of S100 proteins to
RAGE: an update. Biochim Biophys Acta 2009, 1793:993-1007.
9. Boni R, Burg G, Dogouglu A, Ilg EC, Schafer BW, Muller B, Heizmann CW:
Immunohistochemical localization of the Ca
2+ binding S100 proteins in
normal human skin and melanocytic lesions. Br J Dermatol 1997,
137:39-43.
10. Dowen SE, Crnogorac-Jurcevic T: S100 proteins in cancer. Calcium Binding
Proteins 2006, 1:143-149.
11. van Ginkel PR, Gee RL, Walker TM, Hu DN, Heizmann CW, Polans AS: The
identification and differential expression of calcium-binding proteins
associated with ocular melanoma. Biochim Biophys Acta 1998,
1448:290-297.
12. Melle C, Ernst G, Schimmel B, Bleul A, Mothes H, Settmacher U, von
Eggeling F: Different expression of calgizzarin (S100A11) in normal
colonic epithelium, adenoma and colorectal carcinoma. Int J Oncol 2006,
28:195-200.
13. Sakaguchi M, Miyazaki M, Takaishi M, Sakaguchi Y, Makino E, Kataoka N,
Yamada H, Namba M, Huh NH: S100C/A11 is a key mediator of Ca
2
+-induced growth inhibition of human epidermal keratinocytes. J Cell
Biol 2003, 163:825-835.
14. Sakaguchi M, Sonegawa H, Murata H, Kitazoe M, Futami JI, Kataoka K,
Yamada H, Huh NH: S100A11, a dual mediator for growth regulation of
human keratinocytes. Mol Biol Cell 2008, 19:78-85.
15. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A,
Fusenig NE: Normal keratinization in a spontaneously immortalized
aneuploid human keratinocyte cell line. J Cell Biol 1988, 106:761-771.
16. Rogakou EP, Pilch DR, Orr OH, Ivanova VS, Bonner WM: DNA double-strand
breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem
1998, 273:5858-5868.
Gorsler et al. BMC Cell Biology 2010, 11:100
http://www.biomedcentral.com/1471-2121/11/100
Page 9 of 1017. Sakaguchi M, Miyazaki M, Sonegawa H, Kashiwagi M, Ohba M, Kuroki T,
Namba M, Huh NH: PKCα mediates TGFβ-induced growth inhibition of
human keratinocytes via phosphorylation of S100C/A11. J Cell Biol 2004,
164:979-984.
18. Srivastava M, Pollard HB: Molecular dissection of nucleolin’s role in
growth and cell proliferation: new insights. FASEB J 1999, 13:1911-1922.
19. Shibata Y, Muramatsu T, Hirai M, Inui T, Kimura T, Saito H, McCormick LM,
Bu G, Kadomatsu K: Nuclear targeting by the growth factor midkine. Mol
Cell Biol 2002, 22:6788-6796.
20. Daniely Y, Dimitrova DD, Borowiec JA: Stress-dependent nucleolin
mobilization mediated by p53-nucleolin complex formation. Mol Cell Biol
2002, 22:6014-6022.
21. Eichholtz T, de Bont DB, de Widt J, Liskamp RM, Ploegh HL: A
myristoylated pseudosubstrate peptide, a novel protein kinase C
inhibitor. J Biol Chem 1993, 268:1982-1986.
22. Zimmer DB, Cornwall EH, Landar A, Song W: The S100 protein family:
history, function, and expression. Brain Res Bull 1995, 37:417-429.
23. Donato R: Functional roles of S100 proteins, calcium-binding proteins of
the EF-hand type. Biochim Biophys Acta 1999, 1450:191-231.
24. Davey GE, Murmann P, Hoechli M, Tanaka T, Heizmann CW: Calcium-
dependent translocation of S100A11 requires tubulin filaments. Biochim
Biophys Acta 2000, 1498:220-232.
25. Baross A, Schertzer M, Zuyderduyn SD, Jones SJ, Marra MA, Lansdorp PM:
Effect of TERT and ATM on gene expression profiles in human
fibroblasts. Genes Chromosomes Cancer 2004, 39:298-310.
26. Kennedy RD, Gorski JJ, Quinn JE, Steward GE, James CR, Moore S,
Mulligan K, Emberley ED, Lioe TF, Morrison PJ, Mullan PR, Reid G,
Johnston PG, Watson PH, Harkin DP: BRCA1 and c-Myc associate to
transcriptionally repress psoriasin, a DNA damage-inducible gene. Cancer
Res 2005, 65:10265-10272.
27. Lapi E, Iovino A, Fontemaggi G, Soliera AR, Iacovelli S, Sacchi A, Rechavi G,
Givol D, Blandino G, Strano S: S100A2 gene is a direct transcriptional
target of p53 homologues during keratinocyte differentiation. Oncogene
2006, 25:3628-3637.
28. Grimbaldeston MA, Geczy CL, Tedla N, Finlay-Jones JJ, Hart PH: S100A8
induction in keratinocytes by ultraviolet A irradiation is dependent on
reactive oxygen intermediates. J Invest Dermatol 2003, 121:1168-1174.
29. Vujanac M, Fenaroli A, Zimarino V: Constitutive nuclear import and stress-
regulated nucleocytoplasmic shuttling of mammalian heat-shock factor
1. Traffic 2005, 6:214-229.
30. Nizard P, Tetley S, Le Drean Y, Watrin T, Le Goff P, Wilson MR, Michel D:
Stress-induced retrotranslocation of clusterin/ApoJ into the cytosol.
Traffic 2007, 8:554-565.
31. Li Y, Gudjonsson JE, Woods TL, Zhang T, Johnston A, Stoll SW, Elder JT:
Transgenic expression of S100A2 in hairless mouse skin enhances
Cxcl13 mRNA in response to solar-stimulated radiation. Arch Dermatol
Res 2009, 301:205-217.
32. Cohen SB, Ma W, Valova VA, Algie M, Harfoot R, Woolley AG, Robinson PJ,
Braithwaite AW: Genotoxic stress-induced nuclear localization of
oncoprotein YB-1 in the absence of proteolytic processing. Oncogene
2010, 29:403-410.
33. Angelov D, Bondarenko VA, Almagro S, Menoni H, Mongélard F, Hans F,
Mietton F, Studitsky VM, Hamiche A, Dimitrov S, Bouvet P: Nucleolin is a
histone chaperone with FACT-like activity and assists remodeling of
nucleosomes. EMBO J 2006, 25:1669-1679.
34. Stepanova V, Lebedeva T, Kuo A, Yarovoi S, Tkachuk S, Zaitsev S, Bdeir K,
Dumler I, Marks MS, Parfyonova Y, Tkachuk VA, Higazi AA, Cines DB:
Nuclear translocation of urokinase-type plasminogen activator. Blood
2008, 112:100-110.
35. Jerke U, Tkachuk S, Kiyan J, Stepanova V, Kusch A, Hinz M, Dietz R, Haller H,
Fuhrman B, Dumler I: Stat1 nuclear translocation by nucleolin upon
monocyte differentiation. PLoS ONE 2009, 4:e8302.
36. Yoon K, Smart RC: C/EBPa is a DNA damage-inducible p53-regulated
mediator of the G1 checkpoint in keratinocytes. Mol Cell Biol 2004,
24:10650-10660.
37. Gartel AL, Tyner AL: The role of the cyclin-dependent kinase inhibitor
p21 in apoptosis. Mol Cancer Ther 2002, 1:639-649.
doi:10.1186/1471-2121-11-100
Cite this article as: Gorsler et al.: DNA damage-induced translocation of
S100A11 into the nucleus regulates cell proliferation. BMC Cell Biology
2010 11:100.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Gorsler et al. BMC Cell Biology 2010, 11:100
http://www.biomedcentral.com/1471-2121/11/100
Page 10 of 10